AL
CELG

Agran Libbie’s Celgene Corp CELG Stock Holding History

Agran Libbie’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		$4.68M Sell
37,592
-5
-0% -$598 1.1% 36
2016
Q4 		$4.35M Buy
37,597
+250
+0.7% +$27.8K 1.05% 38
2016
Q3 		$3.9M Buy
37,347
+615
+2% +$66.6K 1.12% 32
2016
Q2 		$3.62M Buy
36,732
+555
+2% +$57.4K 0.91% 38
2016
Q1 		$3.62M Buy
36,177
+660
+2% +$68K 0.93% 37
2015
Q4 		$4.25M Buy
35,517
+752
+2% +$87K 1.12% 32
2015
Q3 		$3.76M Sell
34,765
-405
-1% -$50.3K 1.05% 33
2015
Q2 		$4.07M Sell
35,170
-144
-0.4% -$16.5K 1.06% 32
2015
Q1 		$4.07M Buy
35,314
+130
+0.4% +$15.5K 0.97% 35
2014
Q4 		$3.94M Sell
35,184
-513
-1% -$54.1K 0.94% 37
2014
Q3 		$3.38M Sell
35,697
-531
-1% -$47.9K 0.83% 40
2014
Q2 		$3.11M Hold
36,228
– – 0.79% 42
2014
Q1 		$2.53M Sell
36,228
-192
-0.5% -$15.2K 0.68% 50
2013
Q4 		$3.08M Sell
36,420
-800
-2% -$63.3K 0.81% 44
2013
Q3 		$2.87M Sell
37,220
-600
-2% -$42K 0.83% 42
2013
Q2 		$2.21M Buy
+37,820
New +$2.28M 0.64% 51

Other funds holding CELG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Agran Libbie's CELG Position: Q1 2017 in Review

Agran Libbie reduced its Celgene Corp (CELG) stake by 0.01% in Q1 2017, selling an estimated $598 and leaving 37,592 shares worth $4.68M. The position accounts for 1.1% of the portfolio, ranked #36.

Agran Libbie first reported a position in CELG in Q2 2013 and has held it in 16 quarters since. 1,417 funds tracked by Wall St. Rank hold CELG as of Q1 2017.

  • Agran Libbie held 37,592 shares of Celgene Corp worth $4.68M as of Q1 2017.
  • Agran Libbie sold 5 Celgene Corp shares in Q1 2017, an estimated $598.
  • Celgene Corp made up 1.1% of Agran Libbie's portfolio in Q1 2017, its #36 holding.
  • Agran Libbie first reported a position in Celgene Corp in Q2 2013 and has held it in 16 quarters since.
  • 1,417 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2017.

Based on Agran Libbie's 13F filing for Q1 2017, filed 27 Apr 2017.